FCPR16 is a phosphodiesterase 4 (PDE4) inhibitor with little emetic potential, which blocks MPP+ induced oxidative damage in SH-SY5Y cells and neurons via AMPK-dependent autophagy. References: Tang L, Huang C, Zhong J, He J, Guo J, Liu M, Xu JP, Wang HT, Zhou ZZ. Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect. Eur J Med Chem. 2019 Apr 15;168:221-231. doi: 10.1016/j.ejmech.2019.02.026. Epub 2019 Feb 11. PubMed PMID: 30822711.

纯度：≥98%